Suppr超能文献

转录沉默是由核激素受体与共抑制因子之间的异构体特异性和异二聚体特异性相互作用所定义的。

Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors.

作者信息

Wong C W, Privalsky M L

机构信息

Section of Microbiology, Division of Biological Sciences, University of California at Davis, Davis, California 95616, USA.

出版信息

Mol Cell Biol. 1998 Oct;18(10):5724-33. doi: 10.1128/MCB.18.10.5724.

Abstract

Nuclear hormone receptors are ligand-regulated transcription factors that play critical roles in metazoan homeostasis, development, and reproduction. Many nuclear hormone receptors exhibit bimodal transcriptional properties and can either repress or activate the expression of a given target gene. Repression appears to require a physical interaction between a receptor and a corepressor complex containing the SMRT/TRAC or N-CoR/RIP13 polypeptides. We wished to better elucidate the rules governing the association of receptors with corepressors. We report here that different receptors interact with different domains in the SMRT and N-CoR corepressors and that these divergent interactions may therefore contribute to distinct repression phenotypes. Intriguingly, different isoforms of a single nuclear hormone receptor class also differ markedly in their interactions with corepressors, indicative of their nonidentical actions in cellular regulation. Finally, we present evidence that combinatorial interactions between different receptors can, through the formation of heterodimeric receptors, result in novel receptor-corepressor interactions not observed for homomeric receptors.

摘要

核激素受体是受配体调控的转录因子,在后生动物的体内平衡、发育和繁殖过程中发挥着关键作用。许多核激素受体具有双峰转录特性,能够抑制或激活特定靶基因的表达。抑制作用似乎需要受体与包含SMRT/TRAC或N-CoR/RIP13多肽的共抑制复合物之间进行物理相互作用。我们希望能更好地阐明受体与共抑制因子结合的规则。我们在此报告,不同的受体与SMRT和N-CoR共抑制因子中的不同结构域相互作用,因此这些不同的相互作用可能导致不同的抑制表型。有趣的是,同一类核激素受体的不同异构体与共抑制因子的相互作用也存在显著差异,这表明它们在细胞调节中的作用并不相同。最后,我们提供的证据表明,不同受体之间的组合相互作用可通过形成异二聚体受体,导致同源受体未观察到的新型受体-共抑制因子相互作用。

相似文献

引用本文的文献

5
Rescue of a primary myelofibrosis model by retinoid-antagonist therapy.维甲酸拮抗剂治疗挽救原发性骨髓纤维化模型。
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18820-5. doi: 10.1073/pnas.1318974110. Epub 2013 Nov 4.

本文引用的文献

10
Transcriptional control. Sinful repression.转录控制。罪恶的抑制。
Nature. 1997 May 1;387(6628):16-7. doi: 10.1038/387016a0.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验